56 related articles for article (PubMed ID: 2004363)
1. Role of oxidative stress in age dependent hepatocarcinogenesis by the peroxisome proliferator nafenopin in the rat.
Huber W; Kraupp-Grasl B; Esterbauer H; Schulte-Hermann R
Cancer Res; 1991 Apr; 51(7):1789-92. PubMed ID: 2004363
[TBL] [Abstract][Full Text] [Related]
2. Increased susceptibility of aged rats to hepatocarcinogenesis by the peroxisome proliferator nafenopin and the possible involvement of altered liver foci occurring spontaneously.
Kraupp-Grasl B; Huber W; Taper H; Schulte-Hermann R
Cancer Res; 1991 Jan; 51(2):666-71. PubMed ID: 1985784
[TBL] [Abstract][Full Text] [Related]
3. Role of fatty acyl coenzyme A oxidase in the efflux of oxidized glutathione from perfused livers of rats treated with the peroxisome proliferator nafenopin.
Conway JG; Neptun DA; Garvey LK; Popp JA
Cancer Res; 1987 Sep; 47(18):4795-800. PubMed ID: 3621175
[TBL] [Abstract][Full Text] [Related]
4. Effects of the hepatocarcinogen nafenopin, a peroxisome proliferator, on the activities of rat liver glutathione-requiring enzymes and catalase in comparison to the action of phenobarbital.
Furukawa K; Numoto S; Furuya K; Furukawa NT; Williams GM
Cancer Res; 1985 Oct; 45(10):5011-9. PubMed ID: 2862989
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the hepatic effects of nafenopin and WY-14,643 on peroxisome proliferation and cell replication in the rat and Syrian hamster.
Lake BG; Evans JG; Cunninghame ME; Price RJ
Environ Health Perspect; 1993 Dec; 101 Suppl 5(Suppl 5):241-7. PubMed ID: 8013414
[TBL] [Abstract][Full Text] [Related]
6. Enhancement of peroxisomal enzymes, cytochrome P-452 and DNA synthesis in putative preneoplastic foci of rat liver treated with the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Just W; Gibson G; Schulte-Hermann R
Carcinogenesis; 1993 May; 14(5):1007-12. PubMed ID: 8099311
[TBL] [Abstract][Full Text] [Related]
7. Peroxisomal enzyme induction uncoupled from enhanced DNA synthesis in putative preneoplastic liver foci of rats treated with a single dose of the peroxisome proliferator nafenopin.
Grasl-Kraupp B; Huber W; Timmermann-Trosiener I; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2435-7. PubMed ID: 8242878
[TBL] [Abstract][Full Text] [Related]
8. Inhibition instead of enhancement of lipid peroxidation by pretreatment with the carcinogenic peroxisome proliferator nafenopin in rat liver exposed to a high single dose of corn oil.
Huber WW; Grasl-Kraupp B; Stekel H; Gschwentner C; Lang H; Schulte-Hermann R
Arch Toxicol; 1997; 71(9):575-81. PubMed ID: 9285040
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the biological effects of phenobarbital and nafenopin on rat hepatocarcinogenesis.
Préat V; Lans M; de Gerlache J; Taper H; Roberfroid M
Jpn J Cancer Res; 1986 Jul; 77(7):629-38. PubMed ID: 2875050
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
11. Stress-dependent induction of protein oxidation, lipid peroxidation and anti-oxidants in peripheral tissues of rats: comparison of three stress models (immobilization, cold and immobilization-cold).
Sahin E; Gümüşlü S
Clin Exp Pharmacol Physiol; 2007; 34(5-6):425-31. PubMed ID: 17439411
[TBL] [Abstract][Full Text] [Related]
12. Nafenopin, a peroxisome proliferator, depletes hepatic vitamin E content and elevates plasma oxidised glutathione levels in rats.
Lake BG; Gray TJ; Körösi SA; Walters DG
Toxicol Lett; 1989 Feb; 45(2-3):221-9. PubMed ID: 2919403
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferation and modulation of rat liver carcinogenesis by 2,4-dichlorophenoxyacetic acid, 2,4,5-trichlorophenoxyacetic acid, perfluorooctanoic acid and nafenopin.
Abdellatif AG; Préat V; Vamecq J; Nilsson R; Roberfroid M
Carcinogenesis; 1990 Nov; 11(11):1899-902. PubMed ID: 2225320
[TBL] [Abstract][Full Text] [Related]
14. Changes in lipid metabolism and antioxidant defense status in spontaneously hypertensive rats and Wistar rats fed a diet enriched with fructose and saturated fatty acids.
Girard A; Madani S; El Boustani ES; Belleville J; Prost J
Nutrition; 2005 Feb; 21(2):240-8. PubMed ID: 15723754
[TBL] [Abstract][Full Text] [Related]
15. Occurrence of oxidative impairments, response of antioxidant defences and associated biochemical perturbations in male reproductive milieu in the Streptozotocin-diabetic rat.
Shrilatha B;
Int J Androl; 2007 Dec; 30(6):508-18. PubMed ID: 17573857
[TBL] [Abstract][Full Text] [Related]
16. Regulation of CYP4A expression in rat by dehydroepiandrosterone and thyroid hormone.
Webb SJ; Xiao GH; Geoghegan TE; Prough RA
Mol Pharmacol; 1996 Feb; 49(2):276-87. PubMed ID: 8632760
[TBL] [Abstract][Full Text] [Related]
17. Glutathione S-transferase isoenzyme patterns in different subtypes of enzyme-altered rat liver foci treated with the peroxisome proliferator nafenopin or with phenobarbital.
Grasl-Kraupp B; Waldhör T; Huber W; Schulte-Hermann R
Carcinogenesis; 1993 Nov; 14(11):2407-12. PubMed ID: 8242872
[TBL] [Abstract][Full Text] [Related]
18. Effects of a peroxisome proliferator on beta-oxidation and overall energy balance in obese (fa/fa) rats.
Assimacopoulos-Jeannet F; Moinat M; Muzzin P; Colomb C; Jeanrenaud B; Girardier L; Giacobino JP; Seydoux J
Am J Physiol; 1991 Feb; 260(2 Pt 2):R278-83. PubMed ID: 1996714
[TBL] [Abstract][Full Text] [Related]
19. Increased lipid peroxidation and impaired antioxidant enzyme function is associated with pathological liver injury in experimental alcoholic liver disease in rats fed diets high in corn oil and fish oil.
Polavarapu R; Spitz DR; Sim JE; Follansbee MH; Oberley LW; Rahemtulla A; Nanji AA
Hepatology; 1998 May; 27(5):1317-23. PubMed ID: 9581686
[TBL] [Abstract][Full Text] [Related]
20. Is cardiac hypertrophy in spontaneously hypertensive rats the cause or the consequence of oxidative stress?
Alvarez MC; Caldiz C; Fantinelli JC; Garciarena CD; Console GM; Chiappe de Cingolani GE; Mosca SM
Hypertens Res; 2008 Jul; 31(7):1465-76. PubMed ID: 18957818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
